Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease
- 23 June 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 288 (1) , 21-24
- https://doi.org/10.1016/s0304-3940(00)01185-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsPublished by Elsevier ,2003
- Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German populationNeuroscience Letters, 2000
- Gene-gene interaction between interleukin-6 and ?2-macroglobulin influences the risk for Alzheimer's diseaseAnnals of Neurology, 2000
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- Cathepsin D displays in vitro β-secretase-like specificityBrain Research, 1997
- Candidate .gamma.-Secretases in the Generation of the Carboxyl Terminus of the Alzheimer's Disease .beta.A4 Amyloid: Possible Involvement of Cathepsin DBiochemistry, 1995
- Generation of amyloid β protein from its precursor is sequence specificNeuron, 1995
- Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proceedings of the National Academy of Sciences, 1993
- The participation of interleukin-6 in the pathogenesis of alzheimer's diseaseResearch in Immunology, 1992
- Rapid detection and sequencing of alleles in the 3′ flanking region of the Interleukin-6 geneNucleic Acids Research, 1989